Get started
Author

Benjamin J. Gamache

Common Telomere Changes during In Vivo Reprogramming and Early Stages of Tumorigenesis
2017 · Rosa M. Marión, Isabel López de Silanes, et al. · Stem Cell Reports · 39
PDF
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
2017 · John K. Simmons, Aleksandra M. Michalowski, et al. · Molecular Cancer Therapeutics · 33
Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis
2020 · Joy M. Gary, John K. Simmons, et al. · Molecular Cancer Therapeutics · 10
Supplementary Table 1 from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
2023 · John K. Simmons, Aleksandra M. Michalowski, et al.
PDF
supplementary methods from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
2023 · John K. Simmons, Aleksandra M. Michalowski, et al.
Supplementary Figures from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
2023 · John K. Simmons, Aleksandra M. Michalowski, et al.
SupplementalFigures 1-4, Tables from Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis
2023 · Joy M. Gary, John K. Simmons, et al.
Data from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
2023 · John K. Simmons, Aleksandra M. Michalowski, et al.
Data from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
2023 · John K. Simmons, Aleksandra M. Michalowski, et al.
SupplementalFigures 1-4, Tables from Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis
2023 · Joy M. Gary, John K. Simmons, et al.
PDF
Supplementary Table 1 from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
2023 · John K. Simmons, Aleksandra M. Michalowski, et al.
Supplementary Figures from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
2023 · John K. Simmons, Aleksandra M. Michalowski, et al.
Data from Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis
2023 · Joy M. Gary, John K. Simmons, et al.
Data from Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis
2023 · Joy M. Gary, John K. Simmons, et al.
Abstract 2833: Genetic and pharmacologic inhibition of mTOR delays mortality due to thymc lymphoma formation in mice and is associated with decreases in cell cycle proteins
2016 · Shuling Zhang, Joy M. Gary, et al. · Cancer Research
Abstract 2309: Murine model of dual mTORC kinase inhibition identifies CDK6 as a synergistic target in T-ALL
2015 · Joy M. Gary, Jinfei Xu, et al. · Cancer Research
Abstract 5472: Systems pharmacogenomics approach identifies synergistic molecular action of combined MTOR/HDAC inhibition on MYC
2014 · Benjamin J. Gamache, John K. Simmons, et al. · Cancer Research
27th International Mammalian Genome Conference meeting report
2014 · Benjamin Gamache, Sarah R. Leist, et al. · Mammalian Genome
PDF
Abstract 4408: A functional genomics approach for identification of sirolimus sensitizer genes regulated by HDAC inhibitors.
2013 · Benjamin J. Gamache, John Simmons, et al. · Cancer Research
Works count: 19
Citation count: 82
H-index: 3
I10-index: 3
Year
Topic
Type